Quality of life in patients with allergic rhinitis

Citation
Ak. Thompson et al., Quality of life in patients with allergic rhinitis, ANN ALLER A, 85(5), 2000, pp. 338
Citations number
39
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
ISSN journal
10811206 → ACNP
Volume
85
Issue
5
Year of publication
2000
Database
ISI
SICI code
1081-1206(200011)85:5<338:QOLIPW>2.0.ZU;2-L
Abstract
Learning objectives: Reading this article will familiarize the practitioner with ongoing efforts to measure the effects of allergic rhinitis symptoms and its treatments on the health-related quality of life (HRQOL) of patient s. The reader will learn about instruments used to collect HRQOL data, resu lts of studies showing the burden of illness and the effects of treatments on HRQOL, and efforts to interpret the clinical relevance of changes in HRQ OL status. Data sources: Information was gleaned from articles listed in MEDLINE regar ding HRQOL in allergic rhinitis between 1966 and 2000 (English language onl y), and from the personal experiences of the authors. Study selection: Questionnaire validation studies and representative contro lled trials employing measures to assess the effects of allergic rhinitis s ymptoms and its treatments on HRQOL are described. Results from this Review: Allergic rhinitis symptoms can have detrimental e ffects on the physical, psychologic, and social aspects of patients' lives. Clinical trial data suggest a variety of pharmacologic therapies can signi ficantly improve HRQOL in patients with allergic rhinitis. Validated questi onnaires are now available that can easily be used in clinical practice to measure the effects of interventions on HRQOL for individual patients. Conclusions: Evaluating the effects of interventions on HRQOL may be partic ularly important in a non-life-threatening condition such as rhinitis. Heal th-related quality of life measures can be used to indicate the risk/benefi t and the cost/benefit ratios of competing treatment options. Clinicians an d policy makers are already using HRQOL data to evaluate results of medical interventions to guide patient management and reimbursement decisions.